AusBiotech

Building connections across Australia’s life sciences sector has been at the heart of AusBiotech's work for over 38 years. Our CEO, Rebekah Cassidy, and Deputy CEO, Rosanne Hyland, joined health, biotech, and life sciences professionals at the Victorian Networking Reception last night. We thank the Treasurer of Victoria and Minister for Economic Growth, Tim Pallas MP, for hosting the event and telling the story of the momentum happening across Victoria’s—and Australia’s—thriving life sciences sector. It’s always great to reconnect with familiar faces and meet new ones. With only hours until #AusBiotech2024, we’re gearing up for ‘the biggest week in biotech’ – stay tuned.

Gearing up for an exciting pre-conference day at #AusBiotech2024 with three incredible sold-out site tours showcasing Australia's biotech excellence. Here's a sneak peek of what's in store:    1️⃣ La Trobe University : We'll explore the La Trobe Institute for Molecular Science (LIMS), Bio Innovation and Digital Innovation Hubs, home to over 19 companies co-located at Bundoora, and preview the future BioNTech SE mRNA facility. Experience cutting-edge research where technology meets biology.    2️⃣ Monash University Technology Precinct: A world-class innovation hub with a vibrant, connected community. Our tour will include the Monash Biomedical Discovery Institute and the Medicines Manufacturing Innovation Centre - MMIC and engage with experts pushing the boundaries of drug discovery and development as part of the Monash University Clinical Trials Centre.     3️⃣ Melbourne Parkville Precinct: One of the world’s leading biomedical precincts delivers outstanding patient care, cutting-edge research and discoveries, and training to some of the country’s brightest minds. It is home to over 40 world-class biomedical organisations. We'll visit Cell Therapies at Peter MacCallum Cancer Centre and the WEHI (Walter and Eliza Hall Institute of Medical Research) National Drug Discovery Centre, experiencing firsthand the groundbreaking work in advanced therapies and drug discovery.    These tours showcase the incredible ecosystem driving Australia's biotech innovation. A huge thank you to our hosts and all participants for making this possible! A perfect way to start the learning, connection and networking of the #AusBio24 Conference. With thanks to host state partners Global Victoria, Invest Victoria, Department of Jobs, Skills, Industry and Regions The Royal Children's Hospital, The Florey Institute, The Peter Doherty Institute for Infection and Immunity, University of Melbourne

#AusBioInvest 2024, Australia's premier biotech investment event, will bring together local and international health investors at the Park Hyatt on Tuesday, 29 October 2023, in Melbourne. This full-day conference will provide you with a rare opportunity to hear from keynote and panel investor speakers, and 23 private and public companies spanning early to late-stage development, demonstrating the potential of Australia’s life sciences. ✔️Investors - qualified investors are eligible for complimentary registration. Apply now https://lnkd.in/g7bJ5ZTc ✔️Interested delegates - Hear from our line-up of life science companies and network with CEOs, pharma executives and life science investors. A standard registration rate is available here https://lnkd.in/g2DWJfVq AusBiotech is grateful to host state partner Victoria State Government for their ongoing support. #AusBioInv24 Global Victoria, Invest Victoria, Department of Jobs, Skills, Industry and Regions

📢AusBiotech is pleased to announce that Tim Pallas MP, the Victorian Minister for Economic Growth, and the Hon. Natalie Hutchins MP, the Victorian Minister for Jobs and Industry, will both speak at Australia’s biggest week in biotech – at #AusBioInvest2024 and #AusBiotech2024.   The Victorian State Government is the Host State Partner for this year’s AusBioInvest and AusBiotech Conference in Melbourne, running from Tuesday, 29 October until Friday, 1 November.      AusBiotech CEO Rebekah Cassidy highlighted the Victorian Government's partnership and support as a vital contributor to Australia's thriving #lifesciences sector.     “One of the pre-eminent biotechnology industry conferences in the Asia-Pacific region, AusBiotech's four-day conference is Australia's largest annual biotechnology gathering. It convenes Australia’s leading life science players and continues to attract a global audience of delegates and investors,” she said.     Tim Pallas MP, Minister for Economic Growth, will officially open AusBioInvest on 29 October. The one-day AusBioInvest programme will welcome over 250 delegates representing Australia’s leading life science companies and local and global investors at the Park Hyatt, Melbourne.     The Hon. Natalie Hutchins MP, Minister for Jobs and Industry, will formally address the conference's more than 1,500 participants, including 200 international delegates from 20 countries, on 30 October at the Melbourne Convention and Exhibition Centre.      AusBiotech is grateful to Minister Pallas and Minister Hutchins for their ongoing support of Australia’s thriving science sector.    Read our full media release https://lnkd.in/e3TBWJqQ #AusBio24 #AusBioInv24 Global Victoria, Invest Victoria, Department of Jobs, Skills, Industry and Regions

🌟#AusBio24 Keynote: Dr. Intan Oldakowska , biomedical engineer, entrepreneur, and co-founder of three medtech startups, takes us through the incredible journey from a napkin sketch to first-in-human trials. Using Earflo as a case study, Intan will share key insights on identifying unmet clinical needs, developing innovative solutions, and crafting a commercialisation strategy. 📅 Date: Wed, 30 Oct 🕒 Time: 12:30-13:00 📍 Room: Plenary 1 This is just one of the many inspiring and innovative sessions at the AusBiotech 2024 National Conference in Melbourne next week. View the programme and find out more about the other 60+ sessions and 250 speakers https://lnkd.in/gWph8vAv #AusBiotech2024 #Medtech #Biotech #Innovation #Commercialisation With thanks to 2024 host state partner Global Victoria, Invest Victoria, Department of Jobs, Skills, Industry and Regions

📢 Are you ready for the Early-Stage Innovation Forum (ESIF)? ESIF is a rapid-fire pitch competition that gives innovators a unique platform to present their early-stage breakthroughs to a panel of expert judges. Focusing on early-stage human #therapeutics and enabling technology.   A cornerstone of our AusBiotech 2024 National Conference, this exclusive opportunity offers researchers and companies the chance to gather feedback and commercialisation advice on early-stage projects and technologies from a panel of industry experts, corporate VCs, and early-stage investors.   Each presenter has seven minutes to outline the problem they are trying to address, their approach to solving it, the technology’s competitive advantage, development plan, and investment proposal.   Stay tuned until the closing ceremony to find out who wins this year's prize. Last chance to register for regular pricing on Friday. View the full programme at https://lnkd.in/eBB_WT3   📍: Early Stage Innovation Forum, #AusBio24 🕐: 2.00-5.40pm, 30 October 2024 🏢: Breakout Room 2, Melbourne Exhibition & Convention Centre #AusBiotech #AusBio24 #ESIF24 #EarlyStageInnovation #Biotech #Medtech

🚀 AusBiotech is thrilled to have Dr Daniel Timms, inventor of the world’s first durable artificial heart, as the Millis Orator at the AusBiotech 2024 National Conference. The Millis Oration, named in honour of Emeritus Professor Nancy Millis’s pioneering contributions to Australian biotech, is a highlight of the annual conference supported by CSL. As Founder and CTO of BiVACOR, Dr Timms has spent over two decades developing the revolutionary BiVACOR titanium heart—a groundbreaking alternative to heart transplants. In his keynote, The Medical Moonshot—A Decades-Long Quest to Build an Artificial Heart, he’ll discuss the complexities of creating an artificial heart and how cutting-edge tech is turning this vision into reality. At the heart of Dr Timms's innovation is a story about determination and tenacity. 📅 Wednesday 30 October 🕤 9:30 am #AusBio24 #AusBiotech2024 #Medtech #ArtificialHeart Global Victoria, Invest Victoria, Department of Jobs, Skills, Industry and Regions,

🎟️ 𝗘𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲 𝘁𝗵𝗲 #AusBio24 𝗕𝗶𝗼𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗘𝘅𝗵𝗶𝗯𝗶𝘁𝗶𝗼𝗻 𝗵𝗮𝗹𝗹 𝗳𝗼𝗿 𝗳𝗿𝗲𝗲 - 𝘀𝗲𝗰𝘂𝗿𝗲 𝘆𝗼𝘂𝗿 𝗙𝗿𝗶𝗱𝗮𝘆 𝗺𝗼𝗿𝗻𝗶𝗻𝗴 𝘁𝗿𝗮𝗱𝗲 𝗽𝗮𝘀𝘀 Perfect for busy life science professionals, students seeking a budget-friendly option, and potential exhibitors, the Friday Morning Trade Pass is your ideal way to experience the #AusBio24 BioIndustry exhibition. Spend two hours exploring the exhibition hall, connecting with peers, and soaking up the energy of Australia’s biggest biotech event—without committing to a full-day pass. 📅 𝗗𝗮𝘁𝗲: Friday, 1 November ⌛ 𝗧𝗶𝗺𝗲: 8:30am – 10:30am Limited registrations are available—sign up for your free pass today! https://lnkd.in/e4QQs9nW Note, this pass is limited to the BioIndustry Exhibition Hall, but you are welcome to upgrade to a full-day pass to attend some of the most engaging sessions on the final day. #AusBio24 #AusBiotech2024 #BioIndustry

Congratulations to all the Prime Minister’s Prize of Science 2024 winners, announced this week. Alongside Australians, AusBiotech is proud of our homegrown pioneering scientists and innovators, who are shaping the future of healthcare and biotechnology. A special congratulations to Dr. Chris Burns, CEO and MD of Amplia Therapeutics Limited, and Professor Andrew Wilks, who were awarded the Prime Minister’s Prize for Innovation in recognition of their outstanding contribution to drug discovery and development in Australia, specifically the invention of a treatment to help treat myelofibrosis. The drug was discovered when the pair worked at Melbourne-based biotechnology company Cytopia. Amplia Therapeutics Limited CEO and MD, Dr Chris Burns, commented: “I am extremely honoured to be the co-recipient of the 2024 Prime Minister’s Prize for Innovation. Australia does a lot of fantastic early-stage research. What we’ve done in the discovery and development of momelotinib shows that incredible research can be translated here in Australia.” Read more from Amplia, an AusBiotech member https://lnkd.in/gQZfEbfU

📢 AusBiotech is delighted to announce that The Hon. Mark Butler MP, Federal Minister for Health and Aged Care, will join our industry members, international delegates, and investors during Australia’s biggest week in biotechnology. Like our thriving #lifesciences sector, our four-day pre-eminent AusBiotech Conference grows year on year. From Tuesday, 29 October, we will welcome more than 1,500 participants, including 200 international delegates from 25 countries. Minister Butler’s decision to speak at AusBiotech 2024 underscores the importance of Australia’s medical innovators and the life sciences sector more broadly at the national level. AusBiotech CEO Rebekah Cassidy GAICD said the organisation was honoured to have Minister Butler join the Conference this year, noting that there has never been a more important time for health innovation to be at the forefront of national discussions. “Globally, the combined pressures of pandemics, stressed supply chains, chronic disease, aging populations, climate change, health inequities, and geopolitical tensions – along with the rapid pace of innovation – has elevated health innovation topics. “Now is the time for deep conversations regarding our sector’s role in our nation’s future and as part of Australia’s modernised economy." Our industry-led programme has more than 200 speakers across 60 sessions designed by and for our members. Read the full programme here https://lnkd.in/eBB_WT3 #AusBio2024 #biotechnology #thrivinglifesciences